Research

Hormonal

Combination therapies improve blood sugar and lipid levels compared to GLP-1R agonists alone.

Combination therapies may be beneficial for managing blood sugar and lipid levels in patients.

StrongSupportsmedium confidence
Dual-agonist (GLP-1/GIP and GLP-1/GCG) and tri-agonist (GLP-1/GIP/GCG) administration... reduction of blood sugar and lipid levels.
Sulayman A. Lyons et al. · Endocrinology · 2023

Why this rating

The abstract discusses both preclinical and clinical studies.

Source

Synergistic Combinations of Gut- and Pancreas-Hormone-Based Therapies: Advancements in Treatments for Metabolic Diseases

Sulayman A. Lyons et al. · Endocrinology · 2023

reviewCited 13×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →